CoinShares PLC Ordinary Shares (CSHR) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
A side-by-side comparison of CoinShares PLC Ordinary Shares and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSHR
CoinShares PLC Ordinary Shares
$4.84Financial ServicesDelayed quote: Oct 5, 2026, 4:00 PM EDT
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$10.19Financial ServicesDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CSHR vs DMII
growth of $100 · dividends reinvested · last 1yCSHR -54.5% (-54.5%/yr)DMII +2.1% (+2.1%/yr)DMII compounded faster over this window
CSHR DMII
CSHR vs DMII: by the numbers
- •DMII is the larger company ($649M vs $638M market cap).
- •CSHR is profitable (96.80% net margin) while DMII runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CSHR | DMII |
|---|---|---|
| P/E ratio | N/A | 34.78 |
| P/B ratio | N/A | 1.31 |
Profitability
| Metric | CSHR | DMII |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 96.80% | 0.00% |
| ROE | 12.73% | 2.62% |
| ROIC | N/A | -0.28% |
Frequently asked
- Is CSHR or DMII more profitable?
- CSHR runs the higher net margin — CSHR at 96.80% versus DMII at 0.00%.
Go deeper
Dig into the metrics
Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratioCoinShares PLC Ordinary Shares ROEDrugs Made In America Acquisition II Corp. Ordinary Shares ROECoinShares PLC Ordinary Shares operating marginDrugs Made In America Acquisition II Corp. Ordinary Shares operating marginCoinShares PLC Ordinary Shares revenue growthDrugs Made In America Acquisition II Corp. Ordinary Shares revenue growthDrugs Made In America Acquisition II Corp. Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.